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Two self-sufficient CYP102 family encoding genes (Krac_0936 and Krac_9955) from the 
bacterium Ktedonobacter racemifer DSM44963, which possesses one of the largest bacterial 
genomes, have been identified.  
 
Methods  
Phylogenetic analysis of both the encoded cytochrome P450 enzymes, Krac0936 and Krac9955. 
Both enzymes were produced and their turnovers with fatty acid substrates assessed in vitro and 
using a whole-cell oxidation system.  
 
Results 
Krac0936 hydroxylated straight chain, saturated fatty acids predominantly at the ω-1 and ω-2 
positions using NADPH as the cofactor. Krac0936 was less active towards shorter unsaturated 
fatty acids but longer unsaturated acids were efficiently oxidised. cis,cis-9,12-Octadecadienoic 
and pentadecanoic acids were the most active substrates tested with Krac0936. Unusually 
Krac9955 showed very low levels of NAD(P)H oxidation activity though coupling of the 
reducing equivalents to product formation was high. The product distribution of tridecanoic, 
tetradecanoic and pentadecanoic acid oxidation by Krac9955 favoured oxidation at the -4, -5 
and -6 positions, respectively.  
 
Conclusion 
Krac0936 and Krac9955 are self-sufficient P450 monooxygenases. Krac0936 has a preference for 
pentadecanoic acid over other straight chain fatty acids and showed little or no activity with 
dodecanoic or octadecanoic acids. Krac9955 preferably oxidised shorter fatty acids compared to 
Krac0936 with tridecanoic having the highest levels of product formation. Unlike Krac0936 and 
P450Bm3, Krac9995 showed lower activities with unsaturated fatty acids. 
 
General Significance In this study of two of the CYP enzymes from K. racemifer we have 
shown that this bacterium from the Chloroflexi phylum contains genes which encode new 
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The P450 cytochrome (CYP) superfamily of b-type heme-dependent monooxygenases, members 
of which are found in virtually every organism, have a highly conserved tertiary structure and 
share a characteristic protein fold.[1, 2] P450s catalyse the oxidation of a broad array of organic 
substrates, allowing them to perform physiological roles as varied as steroid hormone synthesis 
and the breakdown of xenobiotics.[1-3] As such they are intrinsically linked to the catabolic and 
anabolic pathways of bacteria. The signature reaction of a P450 is the insertion of a single oxygen 
atom from molecular dioxygen into a carbon–hydrogen bond to give the corresponding alcohol, 
the second oxygen atom being reduced to water.[4] These reactions are often carried out with 
high regio- and stereoselectivity.[5, 6] P450-mediated enzymatic oxidation reactions can 
therefore provide efficient biocatalytic routes for generating alcohols from alkanes which are not 
feasible using contemporary organic synthetic methods.[7-10] 
CYP102A1 (P450Bm3) from Bacillus megaterium is a soluble 119.5 kDa enzyme in 
which a 55 kDa P450 heme domain is fused to a 65 kDa reductase domain.[8] It requires only 
NADPH and oxygen to function and hydroxylates fatty acids at sub-terminal positions, close to 
the ω-terminus.[11] It acts on range of saturated straight-chain fatty acids, with pentadecanoic 
acid being the most active with the rates falling away as the chain-length increases or 
decreases.[8] The product profiles of a selection of fatty acids revealed that oxidation at the ω-1, 
ω-2 and ω-3 CH bonds are favoured though there was variation among substrates of differing 
lengths.[12] Longer chain unsaturated fatty acids such as arachidonic, palmitoleic (cis-9-
hexadecenoic) and linoleic (cis,cis-9,12-octadecadienoic) acid are also rapidly and efficiently 
oxidised by CYP102A1.[13, 14] 
Other self-supporting fatty acid oxidising P450s have been identified and investigated 
including CYP505 (P450foxy), a sub-terminal fatty acid hydroxylase from the fungus Fusarium 
oxysporum.[15] Studies of the closely related enzymes from the same family as CYP102A1, for 
example, A2 and A3 from B. subtilis,[16] A5 from B. cereus,[17] A7 from B. licheniformis[18] 
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and CYP102D1 from Streptomyces avermitilis MA4680 have also been reported.[19] Minor 
changes in the fatty acid binding profiles and in the regioselectivity of oxidation are observed 
across these systems. However the consensus among this family of P450 enzymes is that 
oxidation occurs at CH bonds close to the -terminus. For example CYP102A5 oxidised 
hexadecanoic acid to yield a 2:1 ratio of the ω-2 to ω-1 fatty acid alcohols with little or no 
oxidation at ω-3, while CYP102A1 oxidation resulted in a 1:2:1 ratio of the three products.[17] 
The CYP102D1 enzyme is the only self-sufficient CYP102 enzyme from outside the Bacillus 
family of bacteria to be characterised so far. CYP102D1 is a fatty acid hydroxylase but there are 
differences in the types of substrates accepted and oxidised including the aromatic substrates 
indole and anthracene. CYP102D1 was also reported to have optimal activity with octadecanoic 
acid rather than pentadecanoic acid among straight chain, saturated fatty acids. Octadecanoic acid 
was oxidised by CYP102D1 at the ω-1, ω-2 and ω-3 positions in a ratio of 36:61:3 compared to 
CYP102A1 which yielded the same products in the following ratio; 39:47:14.[19] Members of 
the CYP102 family which are not fused to a reductase domain have also been identified. The best 
characterised being CYP102B1 from Streptomyces coelicolor and CYP102H1 from Nocardia 
farcinica.[20, 21] CYP102B1 was found to oxidise arachidonic acid but not hexadecanoic nor 
octadecanoic acids while CYP102H1 was reported to oxidise linoleic acid at the ω-1 position.  
Despite extensive efforts, the precise physiological role of these CYP102 enzymes is not 
yet known. Branched-chain saturated fatty acids, which play a key role in the regulation of 
membrane fluidity, also induced CYP102A1 expression, and it has been suggested that these are 
more likely to be the enzyme's natural substrates, since they account for almost 90% of the fatty 
acid content of Bacilli.[22-24]  
The self-sufficient CYP102 systems exhibit the highest turnover frequency 
(> 1000 min−1) of any CYP enzymes and this overcomes one of the major hurdles to their use as 
catalysts.[8, 17, 25] Therefore these systems have been used as platforms for designing 
monooxygenase biocatalysts via protein engineering. To this end, the effects of various amino 
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acid residues located in the substrate access channel and active site of enzymes have been 
investigated by both site-directed and random mutagenesis.[7, 8, 26-29] Furthermore natural 
variants of CYP102A1 have been found to have slightly differing activities with dodecanoic acid 
and other non-natural substrates.[30]  
Ktedonobacter racemifer DSM44963 (or strain SOSP1-21) is an aerobic, non-motile, 
filamentous, mesophilic, gram-positive heterotroph, capable of growing under microaerophilic 
conditions.[31] It belongs to the Phylum Chloroflexi, or green non-sulfur bacterium, a group of 
bacteria that is highly isolated in the genealogy and comprises, to date, very few organisms. The 
K. racemifer genome has been decoded and is among the largest bacterial genomes with 11,453 
protein-coding genes and therefore provides an opportunity to discover new and interesting 
protein families.[31] There are two potential self-sufficient CYP102 family member encoding 
genes in this bacterium (genes Krac_0936 and Krac_9955). Given its large genome and the 
evolutionary niche occupied by K. racemifer we set out to ascertain if the role of these CYP102 





2.1 Cloning, expression and purification 
The genes encoding full-length Krac0936 and Krac9955 were isolated from the genomic DNA of 
K. racemifer DSM44963 (obtained from DSMZ, Germany) using the polymerase chain reaction 
(PCR) with the following primers; Krac0936 FP, 5′-ttaattcatatgcaaatagaagaaaagacactcg-3′. 
Krac0936 RP, 5′-ttaattaagcttctattagttgccccagacatccaccag-3’ Krac9955 FP, 5′-
ttaattcatatggtacgatcccagctagacaccatc-3’ and Krac9955 RP, 5′-
ttaattaagcttctattaactggtgccccagatgtcg-3′. The restriction sites NdeI and HindIII are highlighted in 
bold and the stop and start codons are underlined. The PCR products were cloned into the vector 
pET26a(+) using the restriction enzyme NdeI and HindIII. The sequences of both genes were 
confirmed by DNA sequencing (Australian Genome Research Facility, Adelaide) using the T7F 









The recombinant plasmids were transformed into Escherichia coli strain BL21(DE3) and the 
transformed cells were cultured in 2xYT medium at 37 C with 30 μg mL–1 kanamycin. When the 
OD600 of the culture reached 0.6 – 0.8 the temperature was reduced to 20 C, 0.5 mM IPTG, 3 mL 
L-1 of trace elements solution (0.74 g CaCl2·H2O, 0.18 g ZnSO4·7H2O, 0.132 g MnSO4·4H2O, 
20.1 g Na2EDTA, 16.7 g FeCl3·6H2O, 0.10 g CuSO4·5H2O, 0.25 g CoCl2·6H2O), and 1 mM 5-
aminolevulinic acid were added in order to induce the production of the protein.  
After further growth for 18 hours at 20 C, cells were harvested by centrifugation, 
resuspended in 40 mM potassium phosphate, pH 7.4, 1 mM in dithiothreitol (buffer P) and lysed 
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by sonication on ice. The crude extracts were then centrifuged at 37000 g for 25 min at 4 C to 
remove the cell debris. The P450s were isolated from the supernatant by ammonium sulfate 
precipitation (30-55% fraction) before desalting using a Sephadex G-25 column pre-equilibrated 
with buffer P. The red coloured protein was loaded onto a GE-Healthcare DEAE fast-flow 
Sepharose column (200 x 50 mm) pre-equilibrated with buffer P from which the protein was 
eluted using a linear gradient of 80-400 mM ammonium sulfate in buffer P. The red P450 
fractions were collected and concentrated by ultrafiltration before storage at –20 °C in 50% (v/v) 
glycerol. Glycerol and salts were removed from proteins immediately prior to experiments using 
a GE Healthcare 5 mL PD-10 desalting column pre-equilibrated with 50 mM Tris buffer, pH 7.4. 
The protein concentration of Krac0936 was estimated using the extinction coefficients of 
CYP102A1.[11] 
2.2 Substrate binding and NADPH turnover rate determinations 
For substrate binding assays the P450 enzymes were diluted to 2.0 µM using 50 mM Tris, pH 
7.4. The high spin heme content was estimated, to approximately ±5%, by comparison with a set 
of spectra generated from the sum of the appropriate percentages of the spectra of the substrate-
free form (>95% low spin, Soret maximum at 418 nm) and camphor-bound form (>95% high 
spin, Soret maximum at 392 nm) of wild-type CYP101A1. 
NADPH turnovers were run in 1200 μL of 50 mM oxygenated Tris, pH 7.4 at 30 °C, 
containing 0.2 μM enzyme and 120 μg bovine liver catalase. Assays were held at 30 °C for 1 min 
prior to addition of 250 M to 1 mM substrate from a 20, 50 or a 100 mM stock in DMSO or 
EtOH. NADPH was added from a 20 mg mL–1 stock to a final concentration of ~320 μM. The 
NADPH oxidation rate was derived using ε340 = 6.22 mM
−1 cm−1.  
2.3 Whole-cell oxidation turnovers 
Cells were grown and protein produced as described above. The resulting cell pellet was 
resuspended in double the volume of E. coli minimal media containing 2% DMSO; (EMM; 
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K2HPO4, 7 g, KH2PO4, 3 g, Na3citrate, 0.5 g, (NH4)2SO4,1 g, MgSO4, 0.1 g, 20% glucose, 20 mL 
and glycerol, 1% v/v in one litre) and added to a baffled flask for increased aeration. The 
substrate was added to a final concentration of 1 mM before shaking at 150 rpm at 30 °C. After 
16 hours the turnover was then centrifuged (15 min, 5000g) and the supernatant isolated. Samples 
(1 mL) of the turnover were taken for analysis via GC-MS.  
2.4 Product analysis 
After the in vitro NADPH oxidation assays or whole-cell incubations had finished 990 μL of the 
reaction mixture was mixed with 10 μL of an internal standard solution (trans-4-phenyl-3-buten-
2-one, 20 mM). For the fatty acids 2 μL of concentrated HCl was added. The mixture was 
extracted three times with 400 μL of ethyl acetate and the organic extracts were combined and 
dried over MgSO4. Solvent was evaporated under a stream of dinitrogen and the sample dissolved 
in 200 μL acetonitrile. For fatty acids excess (25 μL) BSTFA/TMSCl (99:1) was added and the 
mixture left for at least 120 min to produce the trimethylsilyl ester of the carboxylic acid group 
and trimethylsilyl ether of the alcohol, if formed. The reaction mixtures were used directly for 
GC-MS analysis. For straight chain, saturated fatty acids and 10-undecenoic acid the oven 
temperature was held at 120 ºC for 3 min and then increased at 7 ºC min1 up to 220 ºC were it 
was maintained for 7 min (total 24.3 min). For the longer unsaturated fatty acids better separation 
of the products was obtained using the following method; 120 ºC for 3 min then increased to 240 
ºC at a rate of 5 ºC min1 were it was held for 5 min (total 32 min). The retention times for the 
trimethylsilyl (TMS) derivatives are given in the supporting information. Products were 
identified by matching the GC-MS mass spectra to those expected for ω-n trimethylsilyl 
derivatised alcohols. Products were calibrated against derivatised product samples of 12-
hydroxydodecanoic, 15-hydroxypentadecanoic, 3-hydroxytetradeconoic and 16-
hydroxyhexadecanoic acids using the assumption that isomeric mono-oxygenated products would 
give comparable responses (Table S2). Samples containing a range of concentrations of the 
chosen product in 50 mM Tris, pH 7.4 were extracted as above. The ratios of the integrated peak 
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areas of the products and internal standard were determined and plotted against product 
concentration. 
2.5 Phylogenetic analysis 
CYP enzyme sequences were used as given in the National Center for Biotechnology Information 
(NCBI) database or the P450 homepage[32] and the sequence identities and similarities were 
obtained using a BLAST search (at NCBI). Sequence alignments were performed using 
ClustalW. The evolutionary history was inferred by using the Maximum Likelihood method 
based on the Jones-Taylor-Thornton (JTT) matrix-based model.[33] The tree with the highest log 
likelihood is shown. Initial tree(s) for the heuristic search were obtained automatically by 
applying Neighbour-Join and BioNJ algorithms to a matrix of pairwise distances estimated using 
a JTT model, and then selecting the topology with superior log likelihood value. The tree is 
drawn to scale, with branch lengths measured in the number of substitutions per site. All 
positions containing gaps and missing data were eliminated. Evolutionary analyses were 





3.1 Phylogenetic analysis of Krac0936 and Krac9955 
Ktedonobacter racemifer DSM44963 contains two genes, Krac_0936 and Krac_9955, which 
encode proteins which are similar to CYP102A1 (50% and 41% sequence identity, respectively). 
We utilised the Basic Local Alignment Search Tool (BLAST) to search for similar enzymes to 
those encoded by the Krac_0936 and Krac_9955 genes from K. racemifer DSM44963 (whose 
amino acids sequences are henceforth called Krac0936 and Krac9955). Krac0936 (Genbank: 
EFH80345.1) and Krac9955 (Genbank: EFH88481.1) share 52% sequence identity with each 
other across both domains of the protein. Krac0936 is the only other protein in the NCBI database 
which shares >50% similarity with Krac9955 (Table 1). However, Krac0936 has a greater 
sequence homology (54-55%) with other proteins such as the CYP102 type enzymes from 
Bradyrhizobium diazoefficiens USDA 110, (formerly B. japonicum, CYP102A6),[35] 
Rhodopseudomonas palustris HaA2 (CYP102A13),[36] Singulisphaera acidiphila,[37] Afipia 
broomeae[38] and Variovorax paradoxus[39] (Table 1a). Krac9955 shares >40% sequence 
identity with other CYP102A subfamily members while the identity with CYP102D1 and 
CYP505 are <40% (Table 1). Generally Krac0936 has a higher sequence identity with CYP102A 
family members than Krac9955 does. It has >40% identity with CYP102D1 but <40% with 
CYP505.  
When comparing just the heme domains of the two systems (defined in this instance as 
the first 473 amino acids) with other members of the CYP102 family the levels of sequence 
identity and similarities increased slightly (Table S1) indicating that the similarity of the heme 
domain is greater than for the whole enzyme. Given that alignment of the heme domain 
sequences shows that the extremities (residues 1–32 and 447–473) are poorly conserved the 




 In order to better understand the similarity of the CYP102 enzymes from different 
bacterial strains we analysed the phylogenetic relationship of the holoproteins and heme domains. 
Both phylogenetic trees show that Krac0936 and Krac9955 cluster with CYP102A subfamily 
enzymes, rather than the members of the other CYP102 subfamilies (B through to J). However 
there are different levels of sequence correlation within the CYP102A subfamily (Fig. 1 and 
Table 1). The holoproteins, CYP102A1, A2, A3, A5 and A7, which are all from strains of 
Bacillus,[8, 16-18] cluster together along with the enzyme from S. acidiphila. Krac0936 and 
Krac9955 are grouped more closely with other CYP102A holoenzymes including CYP102A6 
from B. diazoefficiens USDA 110, CYP102A11 from Erythrobacter sp. NAP1,[40] and the 
enzymes from R. palustris strains HaA2 and BisB5 (CYP102A13), A. broomeae, V. paradoxus 
and Pseudonocardia asaccharolytica[41] (Fig. 2a). Within this grouping of CYP102A subfamily 
enzymes Krac9955 clusters with the enzyme from P. asaccharolytica.  
 When only the heme domains were considered, the CYP102A subfamily splits into 
three distinct groupings (Fig. 1). Krac9955 and the enzyme from P. asaccharolytica pair together 
but apart from the others. The other two clusters are similar to those observed with the 
holoproteins except that Krac0936 now aligns more closely with the CYP102A enzymes from S. 
acidiphila and the Bacillus species. 
The alignment of the amino acid sequences of Krac0936 and Krac9955 with the other 
CYP102A enzymes shows a great deal of similarity with respect to insertions and deletions (Fig. 
S1 and Table 2). Krac0936 and Krac9955 have a two amino acid insertion at residues 228 
(CYP102A1 numbers given) and two sets of three amino acid insertions at 302 and 385 of the 
heme domain. More significant changes are observed in the linker region between the two 
domains (from residue 470 onwards) and there is a five amino acid insertion at residue 788 in the 
reductase domain. The alignment of the heme domain, which controls substrate binding and 
oxidation, shows that the F/G and G/H loops, the first half of the G-helix and the domain 
extremities (residues 1–32 and 447–473) are poorly conserved (Fig. S1). Despite the relatively 
13 
 
low sequence similarity within the CYP102A subfamily members the residues that are likely to 
be important for core CYP enzyme function are uniform (Table 2). The acid-alcohol pair of the I-
helix, which is involved in proton delivery and oxygen activation,[42, 43] the phenylalanine 
amino acid seven residues towards the N-terminus from the heme iron ligating cysteine,[42] and 
the glutamate and arginine pair (EXXR), which is proposed to be involved in heme 
incorporation,[44] are all conserved across the CYP102A subfamily members analysed in this 
work (Tables 2 and 3).  
The residues that make up the active site of the CYP102 family enzymes can be predicted 
based upon sequence alignment with those found in the structurally characterised 
CYP102A1.[45] A comparison of the residues in the substrate recognition sites; SRS1 (69–92, in 
CYP102A1), SRS2 (181–188), SRS3 (200–208), SRS4 (I-helix, residues 253–271), SRS5 (325–
335) and SRS6 (434–441) and those which have been targeted in previous mutagenesis studies 
can also be informative (Table 3).[29, 46] The Arg47 and Tyr51 residues at the entrance of the 
access channel of CYP102A1 are not conserved across the other CYP102 enzymes, though the 
arginine residue is present in Krac0936 and in the enzyme from S. acidiphila.[47-49] In SRS1, 
Leu86, Phe87 and Thr88 are conserved across all the enzymes analysed here with the exception 
of the equivalent amino acid to Thr88 in Krac9955 which is a serine residue (Table 3). However 
other residues which have been shown to alter the substrate selectivity of CYP102A1 when 
modified such as Ala74, Val78 and Ala82 are not well conserved across the CYP102 
members.[29, 50, 51] The equivalent residues to Ala74, Val78 and Ala82 are proline, asparagine 
and alanine in Krac0936 and asparagine, asparagine and isoleucine in Krac9955. These residues 
are also altered in the other enzymes (Table 3). Leu181 in SRS2 is completely conserved, but 
Leu188 shows considerable variation (glycine and alanine in Krac0936 and Krac9955, 
respectively) across the CYP102A enzymes.[26, 51] Ala184 is maintained among the CYP102A 
subfamily members from strains of Bacillus but not those from the other bacteria (except P. 
asaccharolytica). Ala184 is modified to serine in Krac0936 and threonine in Krac9955 (Table 3). 
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The residues of SRS3 show considerable variation and it has been reported that they are not 
critical for substrate binding in CYP102A1. Structural comparisons have also led to the proposal 
that SRS3 is not a substrate recognition site in the CYP102 family.[52] 
In the I-helix and SRS4 many of the important active site residues are conserved for 
example Thr260, Ile263 and Ala264. Although variations are found in other enzymes at the 
equivalent residue to Ile259 it is conserved in Krac0936 and Krac9955 (Table 3). SRS5 which is 
just after the glutamate and arginine pair (EXXR) contains two prolines which are conserved in 
all the CYP102A subfamily enzymes analysed here but not CYP102D1. Ala328 and Ala330 
which have been targeted in several mutagenesis studies (both site-directed and directed 
evolution) are conserved in many of the CYP102A enzymes.[27, 53-57] Ala328 is completely 
conserved, with the exception of CYP102D1, while Ala330 shows more variation in the non-
Bacillus CYP102 enzymes. This alanine is modified to leucine in Krac0936 and methionine in 
Krac9955 (Table 3). The key active site residues in SRS6 are conserved across all of the 
CYP102A subfamily enzymes and the equivalent residues to Leu437, Thr438 and Lys440, are 
found in all the of the enzymes considered here.[47] Other modifications to the residues of the 
proposed substrate recognition sites are shown in Table 3 and Table S1a. Overall more of the 
residues of the SRSs in CYP102A1 are conserved in Krac0936 than in Krac9955. 
Kim and co-workers identified an 34ADELGPIE41 sequence in the CYP102A1 enzyme 
(reported as AXEXGPIF in the other CYP102A subfamily members) at the entrance to the access 
channel which was modified in CYP102D1.[19] This region is somewhat conserved across the 
CYP102A subfamily enzymes evaluated here but there are some variations in Krac0936 
(ARELGPIY) and Krac9955 (AQRHGPIF, Table 2).  
The residues in the reductase domain of these self-sufficient enzymes which have been 
shown to be important in FMN and FAD binding and in controlling the redox properties of these 
enzymes are conserved (Table S1b and c). These include those corresponding to Ser965, Arg966, 
Lys972, Tyr974 and Trp1046 of CYP102A1, which are all close to the FAD cofactor and are 
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important in the specificity of this enzyme for NADPH over NADH.[58] The residues Ser490, 
Asn491, Try536, Asn537, Trp574 and Thr577 of CYP102A1 which interact with the FMN 
cofactor are also conserved in Krac0936 and Krac9955 (Table S2).[59] 
Overall the conservation of many of these residues in the active site, the substrate access 
channel and the reductase domain suggest a similar function for the CYP102A enzymes. 
However, modifications in the sequence of the heme domain are likely to be responsible for the 
alterations in substrate binding affinity and product distributions which are observed across the 
family.[8, 15-19, 60] These differences are greater in the non-Bacillus members of the CYP102A 
subfamily including Krac0936 and Krac9955 (vide infra). Krac0936 and Krac9955 notably 
occupy a different phylogenetic space than the CYP102A enzymes from Bacillus bacteria, though 
the heme domain of Krac0936 seems to share more similarity when considered separately 
compared to the whole protein. Based on the differences in the amino acid sequences outlined 
above the self-sufficient enzymes from other bacteria, and in particular Krac9955, may interact 
differently with fatty acids, act on divergent substrates or have distinct functions. 
3.2 Protein production and fatty acid oxidation using whole-cell oxidation systems 
The Krac0936 and Krac9955 enzymes were produced using E. coli. When compared to 
CYP102A1, which was used as a control, the levels of protein production for both were observed 
to be low (Fig S2). E. coli cells producing Krac0936 were faint orange in colour compared to 
those of Krac9955 which were beige whereas those of CYP102A1 were distinctly orange 
coloured. Codon analysis of the genes Krac_9955 and Krac_0936 indicated that there were more 
clusters of rare codons in Krac_0936 than in CYP102A1 (Fig. S3). In addition Krac_9955 
contained particularly high densities of rare codon clusters (Fig. S3) and this, alongside poor 
heme incorporation and protein folding, may be potential reasons for the low level of protein 
production using E. coli. 
We attempted to purify the proteins using two ion exchange chromatography steps, a 
method which results in pure protein with CYP102A1.[26] Krac0936 could be purified in low 
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yamounts using this method. The yield of Krac0936 was increased by incorporating an 
ammonium sulfate precipitation step before the first ion exchange chromatography step. SDS-
page analysis indicated protein of the correct size (Krac0936; 121.4 kDa) was being generated 
(Fig. S2). After purification, Krac0936 was tested for the characteristic Soret absorbance of a 
reduced ferrous CO-bound P450. The binding of CO to the ferrous form results in a shift of the 
Soret peak to 450 nm, indicating the viability of the Krac0936 enzyme (Fig. S4).[61] A shoulder 
at 420 nm was observed, which may be due to an impurity not removed during purification or 
could arise from the act of bubbling CO through the protein sample, which, if performed too 
vigorously, can denature sensitive P450 enzymes. The levels of Krac9955 production using E. 
coli were too low for purification. After ammonium sulfate precipitation and ion exchange 
chromatography a crude mixture of proteins from the cell lysate containing Krac9955 could be 
isolated. SDS page analysis revealed a mix of proteins with a small band at the correct mass 
(Krac9955 122.2 kDa, not shown). 
Investigation of the substrate range and product distributions of the Krac0936 and 
Krac9955 enzymes was initially undertaken by taking advantage of the self-sufficient nature of 
the CYP102A subfamily members. E. coli whole-cell systems producing each enzyme were used 
to study the oxidation of dodecanoic, tetradecanoic and hexadecanoic acids. Aliquots of the 
supernatant were extracted and analysed via GC-MS after BSTFA/TMSCl derivatisation. The 
CYP102A1, Krac0936 and Krac9955 whole-cell oxidation systems all resulted in the generation 
of hydroxylated fatty acid products from dodecanoic acid indicating that functional holoenzyme 
is being generated in E. coli (Fig. 2, Fig. S5 and S6).  
Three main products were observed in the turnovers with CYP102A1 for all three acids 
(Fig. S5). These products were also observed in the whole-cell turnovers of Krac0936 and 
Krac9955 with dodecanoic acid and these were identified as the ω-1, ω-2 and ω-3 hydroxylated 
fatty acids by analysis of the mass spectra of the derivatised products (Scheme 1, Fig. 2 and S7). 
Analysis of the mass spectrum fragmentation pattern of the three products showed an increase in 
17 
 
the base peak at m/z 117.1, 131.1 and 145.1 AMU, respectively. This is consistent with cleavage 




+, respectively. Confirmatory additional peaks were found for the ω-1, ω-
2 and ω-3 hydroxylated fatty acids at the expected molecular weight of the doubly derivatised 
product minus 15, for ω-1, minus 29 for ω-2 and minus 43 for ω-3 (Fig. S7). 
The Krac9955 whole-cell oxidation system resulted in diminished levels of metabolite 
formation compared to Krac0936, presumably due to the low levels of protein production. The 
oxidation of tetradecanoic acid by Krac9955 was significantly less active when compared to 
Krac0936 and CYP102A1 (Fig. S5 and S6). The oxidation of hexadecanoic acid by Krac0936 
generated low levels of hydroxy-fatty acids (ω-1, ω-2 and ω-3) and analysis of the Krac9955 
turnovers assays showed no detectable product.  
The ratios of the products formed were calculated by integrating the areas of the peaks. As 
reported in the literature CYP102A1 hydroxylated the substrates in all three positions with no 
clear preference and the ratios of hydroxylation at the three sites differed with the chain length of 
the substrates (Table 4 and Fig. S5).[8] Krac0936 catalysed oxidation of the fatty acids generated 
the same three hydroxy fatty acids as CYP102A1 but with altered regioselectivity. Each showed 
minimal levels of oxidation at ω-3 (<10%). An almost equal preference for the ω-1 and ω-2 
positions was observed with dodecanoic acid (Fig. 2). However with tetradecanoic acid there was 
a greater preference for hydroxylation at ω-1 (Fig. S6). There was an absence of ion peaks 
corresponding to the cleavage fragments of CH2OSiMe3
+
 (103.1 AMU),
 which would correspond 
to hydroxylation at the ω position. 
Krac9955 oxidation of dodecanoic acid showed a strong preference for hydroxylation at 
the ω-3 position (Fig. 2). Very little oxidation was detected at the -1 position and in addition we 
observed low levels of oxidation at the -4 and -5 positions (-4; m/z 159.1 AMU, 
CH3(CH2)3CHOSiMe3




+, and an additional peak at 289.1 AMU; 360 minus 71, Table 4, 
Scheme 2, Fig. S7). The low levels of oxidation in the tetradecanoic acid turnover prevented 
accurate quantitation of the product distribution but the major products arose from oxidation at 
the -4 and -5 C-H bonds with small peaks due to oxidation at more terminal C-H bonds being 
observed (Fig. S6 and S7).  
All of the whole-cell turnovers including CYP102A1 generated the greatest amount of 
product with dodecanoic acid. As dodecanoic acid has the highest solubility it would allow the 
substrate to cross the cell membrane more easily, enabling the enzyme to oxidise it. Therefore the 
results from the whole-cell oxidation systems cannot be interpreted as a direct measurement of 
relative enzyme activity and substrate preference. For example with straight chain, saturated fatty 
acids CYP102A1 is reported to have the highest in vitro activity with pentadecanoic acid and has 
a higher activity with tetradecanoic acid than dodecanoic acid.[8] 
3.3 In vitro analysis of Krac0936 and Krac9955 activity with straight chain saturated fatty acids 
The purification of Krac0936 allowed qualitative assessment of the spin state of the heme iron 
upon the addition of various straight chain fatty acid substrates using UV/Vis analysis. It was 
found that pentadecanoic acid binding drives the heme iron to the high-spin five-coordinate heme 
form which absorbs at ~390 nm, 65% HS, with the other fatty acid substrates resulting in lower 
spin-state shifts (Fig. S8). Tridecanoic acid induced the next highest shift to the high spin form, 
50% HS, with those of dodecanoic, tetradecanoic, and hexadecanoic acids being much lower. By 
way of comparison the spin state shifts observed with CYP102A1 after addition of dodecanoic, 
tetradecanoic and hexadecanoic acids were reported as 40%, 65% and 95%, respectively.[25] 
We also monitored the NAD(P)H oxidation activity of Krac0936 with these saturated 
fatty acid substrates (Table 6). Addition of NADH did not support monooxygenase activity while 
NADPH was oxidised by Krac0936 in the presence of pentadecanoic acid. In agreement with 
spin state shift data pentadecanoic acid resulted in the highest rate of NADPH oxidation (Fig. 3). 
Tetradecanoic acid brought about the next highest activity, followed by tridecanoic acid and 
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hexadecanoic acid (Table 6). Heptadecanoic acid showed low levels of NADPH oxidation 
activity and addition of dodecanoic acid resulted in a rate that was not elevated above that of the 
leak rate (Table 6 and Fig. 3). It was also found that the enzyme had little or no activity with the 
equivalent fatty alcohols and methyl esters (C12, C14 and C16, Table 6). 
The products of the in vitro oxidations were analysed by GC-MS. The turnovers of fatty 
alcohols and methyl esters did not yield any observable product arising from monooxygenase 
activity. In contrast to the whole-cell oxidation systems the in vitro turnover of dodecanoic acid 
by Krac0936 generated the lowest amount of product with the coupling of product formation to 
NADPH reducing equivalents being only 8% (Table 6 and Fig. S9). The formation of ω-1, ω-2 
and ω-3 alcohols by Krac0936 were assigned in the same manner as previously described and the 
product distribution broadly agrees with those obtained from the whole-cell oxidation system 
(Table 4). The turnovers of the other fatty acid substrates also generated the ω-1, ω-2 and ω-3 
products (Scheme 1) with pentadecanoic acid having the highest coupling efficiency, 83%. The 
amount of product decreased if the chain length was shorter or longer than C15 (Table 6 and Fig. 
4a-d). The coupling efficiency of hexadecanoic acid turnovers was high (60%) while that of 
heptadecanoic acid was lower. No product was observed for longer fatty acids (Table 6). The 
coupling efficiencies of the turnovers of tetradecanoic and tridecanoic acids were also high 
(>61%) before a sharp drop off for shorter fatty acids (Table 6).  
All of the Krac0936 catalysed fatty acid turnovers generated very little product at the ω-3 
position with the major products arising from oxidation at ω-1 and ω-2 (Table 6, Fig. 4a-d, and 
Fig. S9). Like those of dodecanoic acid the monooxygenase turnovers of pentadecanoic and 
tridecanoic acids showed minimal selectivity between the ω-1 and ω-2 CH bonds. 
Tetradecanoic acid oxidation by Krac0936 was the most selective for alcohol formation at ω-1 
with hexadecanoic acid showing a slight preference for oxidation at ω-2 (Table 4). Deviation in 
the product distribution between the in vitro and in vivo turnovers was observed in the Krac0936 
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oxidation of hexadecanoic acid and this may arise from the low level of metabolite formation in 
the whole-cell turnover making accurate quantitation more difficult (Table 4). 
The low production levels of Krac9955 in E. coli prevented the generation of significant 
quantities of the enzyme in a pure form impeding detailed in vitro characterisation. However we 
performed activity assays on the crude mixture obtained after ammonium sulfate precipitation 
and ion-exchange chromatography. The activity was low for all of the fatty acids with no 
detectable increase in the NADPH oxidation above the leak rate. However significant levels of 
product were generated for undecanoic (coupling 34%) through to pentadecanoic acids (coupling 
73%, Table 6). In agreement with the whole-cell oxidation data, the Krac9955 turnover of 
hexadecanoic acid resulted in no product formation. Turnover of decanoic acid resulted in very 
low levels of hydroxylated fatty acids (coupling; 7%). Tridecanoic acid oxidation generated the 
highest total amount of hydroxylated fatty acid metabolites with the coupling of the reducing 
equivalents to product formation being 93% (Table 6). Moderate but lower levels of alcohol 
products were observed with dodecanoic, tetradecanoic and pentadecanoic acids (69-86%, Table 
6). No oxidation products arising from monooxygenase activity were observed for fatty alcohols 
or methyl esters (C12, C14 and C16) and no activity was detected with NADH (data not shown). 
With dodecanoic acid the major product was at the -3 position (72%) in agreement with 
the data from the whole-cell oxidation system (Fig. 2 and Table 5). The main minor product was 
at -2 with low levels of oxidation at the -1, -4 and -5 positions being observed, vide supra 
(Table 5). Increasing or reducing the length of the fatty acid resulted in a systematic change in the 
product distribution. The major product arising from the undecanoic acid turnovers was 9-
hydroxyundecanoic acid (-2, 78%) with minor products at -1 and -3 (Fig. 5a). The major site 
of oxidation of tridecanoic was at -4 (56%) with -3 and -2 as the main minor products (Fig. 
5b and Table 5). Small amounts of the -1, -5 and -6 (m/z 187.1 AMU, 
CH3(CH2)5CHOSiMe3
+ and 289.2 AMU; 374 minus 85) alcohols were also observed (Table 5 
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and Fig. S7). As the chain length of the fatty acid increased in tetradecanoic and pentadecanoic 
acid the positions of CH bond oxidation moved to increasing subterminal positions and became 
less selective. For tetradecanoic acid the major products were -4 and -5 (Table 5 and Fig. 5c) 
and for pentadecanoic acid the fatty acid oxidation predominantly occurred at -6, -5 and -4 
(Table 5 and Fig. 5d). The minor products also shifted towards the carboxyl group with oxidation 
products being observed at -7 (m/z 201.2 AMU, CH3(CH2)6CHOSiMe3
+ and 289.2 AMU; 388 
minus 99, Fig. S7) for tetradecanoic acid while for pentadecanoic acid low levels of an additional 
minor product at -8 were also observed (-8; m/z 215.2 AMU, CH3(CH2)7CHOSiMe3
+ and 
289.2 AMU; 402 minus 113, Table 5 and Fig. S7). The oxidation of decanoic acid by Krac9955 
was inefficiently coupled generating little product compared to undecanoic and dodecanoic acid 
(Table 6 and Fig. S10). The product distribution was unusual with -1 and -3 being the major 
products and lower levels of -2 being observed (Table 5). There was no evidence of oxidation at 
the terminal or the -4 positions.  
3.4 Analysis of the activity of Krac0936 and Krac9955 with unsaturated chain fatty acids 
All the CYP102A family enzymes from Bacillus strains, with the exception of CYP102A7, have 
been reported to turnover certain unsaturated fatty acids at higher activities than the saturated 
analogues.[8, 16-18] Like CYP102A7, the fungal enzyme CYP505A1 has lower activity with 
unsaturated fatty acids whereas the activity of CYP102D1 with saturated and unsaturated fatty 
acids is comparable.[15, 19, 62] cis-9-Octadecanoic (oleic) acid induced an 80% shift to the high-
spin form on addition to Krac0936 with cis,cis-9,12-Octadecadienoic (linoleic) inducing a lower 
shift (50%, Fig. S8). cis-9-Hexadecenoic (palmitoleic) acid also induced a higher shift than both 
hexadecanoic and pentadecanoic acids but that caused by cis-9-tetradecenoic (myristoleic) acid 
was low (Fig. S8). 
Krac0936 was less active with cis-9-tetradecenoic acid than tetradecanoic acid (Table 6). 
The turnover generated two hydroxylated metabolites (coupling efficiency 19%) with a clear 
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preference for oxidation at the -1 position, 93%, over -2, 7% (Scheme 1 and Fig. 6a). The 
turnover activity of cis-9-hexadecenoic acid by Krac0936 was lower than that of hexadecanoic 
acid due to reduced NADPH oxidation rates but the coupling efficiency was greater (Table 6). 
The turnover resulted in a product distribution ratio of 70:18:12 for the -3:-2:-1 alcohols a 
significant change compared to the saturated fatty acids (Fig.6b). cis-9-Octadecenoic acid was 
turned over by Krac0936 with a NADPH oxidation rate comparable to that of pentadecanoic acid 
but the coupling was lower resulting in a reduced product formation rate for the unsaturated fatty 
acid (Table 6, Scheme 1 and Fig. 3). The products generated were confined to the -1, -2 and 
-3 positions with only 10% at -3 and a roughly equal amount of the -1 and -2 alcohols 
(Table 4, Fig. 6c and Fig. S7). cis,cis-9,12-Octadecadienoic acid was the most active substrate 
tested having the highest NADPH activity and a product formation rate comparable to 
pentadecanoic acid (Table 6). The major metabolite was formed from hydroxylation at -2 (74%) 
with oxidation at -1 being the main minor product (24%) and just 2% selectivity for -3 (Table 
4, Fig. 6d and Fig. S7). 
 The longer unsaturated, C18, fatty acids were not turned over by Krac9955. cis-9-
Hexadecenoic and cis-9-tetradecenoic acids were oxidised albeit with lower levels of coupling 
(12-14%) compared to tetradecanoic acid (Table 6). The major product arising from the turnover 
of cis-9-hexadecenoic acid was the epoxide with the allylic alcohol at -8 (m/z = 213.2 AMU, 
CH3(CH2)5CH=CHCHOSiMe3
+) being the only other product detected (Table 5 and Scheme 2). 
The epoxidation products were identified by GC-MS co-elution with standards of the epoxides 
generated by reaction of the unsaturated fatty acids with m-chloroperbenzoic acid and analysis of 
the MS fragmentation patterns (Fig. S7). GC-MS analysis revealed that other potential minor 
products may be present but the MS spectra of these were not consistent with those of likely 
hydroxylation products and these peaks may arise from impurities (Fig. S9). For the oxidation of 
cis-9-tetradecenoic acid the epoxide was also the major product with allylic oxidation at -6 (m/z 
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= 185.25 AMU, CH3(CH2)3CH=CHCHOSiMe3
+) being the minor product (Table 5, Scheme 2, 
Fig. 7a and Fig. S7).  
Given the preference of Krac9955 for shorter chain fatty acids we also tested 10-
undecenoic acid as a substrate. This generated less product than the turnover of undecanoic acid 
(coupling 12%, Table 6) but the reaction was 100% regioselective for oxidation at the allylic -2 
CH bonds (m/z = 129.1 AMU, CH2=CHCHOSiMe3
+, Scheme 2, Fig. 7b and Fig. S7). 
Overall Krac0936 is selective for the oxidation of fatty acids and not the equivalent 
alcohols or methyl esters. It is has a preference for pentadecanoic acid over the other straight 
chain fatty acids. Tetradecanoic acid showed moderate activity followed by tridecanoic acid and 
the hexadecanoic and heptadecanoic acids. While dodecanoic acid was hydroxylated, the activity 
was very low and octadecanoic was not hydroxylated. Krac0936 showed a preference for 
hydroxylation of straight chain, saturated fatty acids at the ω-1 and ω-2 positions with low levels 
of oxidation at the ω-3 position. The preference of the ω-1 position is greatest for tetradecanoic 
acid. Unlike all the previously characterised CYP102 and CYP505 family members, including 
Krac0936 from the same bacterium, the selectivity of fatty acid oxidation by Krac9955 shifts the 
product selectivity significantly away from the -1, -2 and -3 sub-terminal positions as the 
length of the fatty acid side chain increases (Fig. S11). Krac0936 was able to efficiently oxidise 






Krac0936 and Krac9955 are self-sufficient, fatty acid oxidising, heme monooxygenases from the 
CYP102 family. They share many similarities to the previously studied CYP102A1, A2, A3, A5, 
A7 and CYP102D1 but there are differences in their activity with saturated and unsaturated fatty 
acids. Both, Krac0936 and Krac9955 function efficiently on a narrower range of straight chain 
saturated fatty acids compared to CYP102A1. The activity of Krac0936 is highest with 
pentadecanoic acid but does not oxidise C11 or C18 saturated fatty acids while dodecanoic and 
heptadecanoic acids are poor substrates. The optimal activity of Krac9955 is with tridecanoic 
acid. It does not oxidise hexadecanoic acid and has minimal activity with decanoic acid.  
Krac0936 showed a preference for oxidation at the -1 and -2 carbons and very low 
levels of oxidation at -3 (<10%). With tetradecanoic acid the selectivity for oxidation at -1 
was 73%. With other self-sufficient enzymes from the Bacillus and fungal species the distribution 
of the products is spread more evenly across these three sub-terminal positions. CYP102A5, from 
Bacillus cereus, showed the highest preference for the -1 and -2 positions (Table S3). 
However, unlike Krac0936, oxidation at -2 over -1 is favoured. Krac9955 shows an even 
more dramatic departure from the product distributions of the previously studied CYP102 family 
members. The favoured positions of hydroxylation on the fatty acid shifted towards the centre of 
the molecule as the chain length increased with the preferred site of oxidation being eight carbons 
away from the carboxylic acid group. These modifications in substrate and product selectivity 
must be related to changes in the size and shape of the active site as a result of changes in the 
primary structure between the CYP102 enzymes.  
Krac0936 was more active towards longer unsaturated fatty acids in line with activities 
observed with other CYP102A subfamily enzymes. So while octadecanoic acid is not 
hydroxylated by Krac0936 the addition of one or two alkene functionalities results in significant 
increases in the product formation activity. Oxidation at -1, -2 and -3 positions was still 
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favoured though there was an increased preference for oxidation at -3 for cis-9-hexadecenoic 
acid. The presence of the second double bond in cis,cis-9,12-octadecadienoic acid closer to the  
terminus compared to cis-9-octadecadienoic acid altered the product distribution to favour 
oxidation at -2. No products arising from epoxidation were observed in the turnover mixtures of 
Krac0936 and cis-9-hexadecenoic acid which may reflect the increased preference for this 
enzyme for the CH bonds closer to the  terminus compared to CYP102A1.[13] Krac9955 does 
not oxidise the longer unsaturated fatty acids (C18). 10-Undecenoic acid was regioselectively 
oxidised by Krac9955 at -2. However the product formation was reduced compared to 
undecanoic acid. The level of product generated with unsaturated C14 and C16 fatty acids was 
low and only products arising from allylic CH bond oxidation and epoxidation were observed 
and characterised. 
Phylogenetic analysis showed that Krac0936 and Krac9955 cluster with members of the 
CYP102A subfamily. The CYP102 subfamilies (B-J) show lower sequence homology. It is of 
note that some of the other subfamilies such as B, C, H and E are not self-sufficient enzymes and 
would require separate electron transfer proteins. A set of CYP102A enzymes from gram 
negative bacteria including A13 (both HaA2 and BisB5 from R. palustris strains), A6, A11 and 
the enzymes from A. broomeae and V. paradoxus cluster together and were clearly separated 
from the Bacillus members of this P450 family. None of these enzymes have been characterised. 
K. racemifer and Streptomyces are gram positive strains of bacteria while Bacillus species are 
gram negative. Krac9955 is closely related to a CYP102 enzyme from P. asaccharolytica which 
is also gram positive. The heme domain Krac0936 is grouped together with the enzyme from the 
gram positive S. acidiphila and to a lesser extent with the Bacillus CYP102 family members.  
It seems that the different CYP102 enzymes may have evolved to undergo different 
functions within cellular metabolism that are unique to the bacterium in which they are found. 
This hypothesis is supported by differences in the amino acid sequences of the residues which are 
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expected to line the active site and access channel of the enzymes. These differences would be 
expected to result in the observed alterations in the substrate range and product distributions. The 
critical amino acids involved in the mechanism of oxygen activation and electron transfer seem to 
be well conserved across the self-sufficient species as are other important residues in the active 
site such as Phe87 in SRS1 and Leu437 in SRS6 (CYP102A1 amino acid sequence given). 
More detailed characterisation of the pure proteins including structural studies and 
substrate binding and activity assays would enable further insight into differences between the 
CYP102 enzymes. The different product selectivity and the low NADPH oxidation activity of 
Krac9955 compared to the other CYP102 family members is particularly intriguing. Despite the 
relatively efficient whole-cell oxidation of shorter chain fatty acids, the low levels of protein 
production of Krac0936 and, in particular, Krac9955 would hamper efforts to apply these 
enzymes as biocatalysts. The GC content of Ktedonobacter racemifer and of the Krac_0936 and 
Krac_9955 genes is not particularly high (53.8%, 60.0% and 55.3%, respectively compared to the 
K12 strain of E. coli which has GC content of 50.8%). However the presence of groups of rare 
codons in Krac0936 and in particular Krac9955 compared to CYP102A1 could oppress protein 
production of these long proteins in E. coli. As yet we cannot rule out that heme or flavin 
incorporation may be suboptimal in these systems. 
The observation of the less promiscuous nature of Krac0936 and Krac9955 for saturated 
fatty acids compared to the other CYP102A1 is interesting. All other CYP102 enzymes studied, 
with the exception of CYP102A7, show a preference for polyunsaturated fatty acids such as 
(5Z,8Z,11Z,14Z)-5,8,11,14-eicosatetraenoic acid (arachidonic acid). The CYP102A1 enzyme and 
others have also been shown to oxidise branched fatty acids which are present in B. megaterium. 
Detailed analysis of the substrate binding and of the product distributions of Krac0936 and 
Krac9955 with branched and polyunsaturated fatty acids would also be informative. The 
selectivity, both regio- and stereo-, of the hydroxylation and epoxidation of these substrates 
would also be of significant interest. The fatty acid spectrum of K. racemifer DSM44963 consists 
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of iso-methylpentadecanoic acid (iso-C16:0, 20.1%) as the most frequent fatty acid, followed by 
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Table 1 The sequence identities of the CYP102 enzymes from K. racemifer DSM44963; (a) Krac0936 and (b) Krac9955 with selected other 
CYP102A subfamily members including CYP102A1 (CYP102A1; B. megaterium), CYP102A2 (B. subtilis), CYP102A3 (B. subtilis), 
CYP102A5 (B. cereus), CYP102A6 (Bradyrhizobium diazoefficiens USDA 110), CYP102A7 (B. licheniformis), CYP102A11 (Erythrobacter 
sp. NAP1), CYP102A13HaA2 and CYP102A13BisB5 (the HaA2 and BisB5 strains of Rhodopseudomonas palustris). Also included are 
CYP102D1 (Streptomyces avermitilis), CYP505 (Fusarium oxysporum) and CYP102 members from Singulisphaera acidiphila, Pseudonocardia 
asaccharolytica, Smaragdicoccus niigatensis, Nakamurella multipartita, Afipia broomeae and Variovorax paradoxus. Sequences and 




Protein; Krac0936 Accession number Identities Positives Gaps 
Score/     
(out of 2238) 
      
S. acidiphila WP_015249791 600/1082(55%) 764/1082(70%) 
  
10/1082(0%) 1219 
CYP102A6 BAC48147 592/1078(55%) 
  
751/1078(69%) 18/1078(1%) 1200 
A. broomeae WP_006019711 583/1075(54%) 754/1075(70%) 9/1075(0%) 1199 
CYP102A13BisB5 ABE39056 581/1070(54%) 747/1070(69%) 
  
5/1070(0%) 1162 
V. paradoxus WP_019657533 588/1079(54%) 
  
741/1079(68%) 20/1079(1%) 1152 
CYP102A13HaA2 ABD08340 574/1072(54%) 734/1072(68%) 12/1072(1%) 1150 
Krac9955 EFH88481 550/1059(52%) 744/1059(70%) 24/1059(2%) 1123 
CYP102A11 WP_007165056 546/1072(51%) 715/1072(66%) 14/1072(1%) 1088 
CYP102A7 WP_003183869 551/1067(52%) 711/1067(66%) 15/1067(1%) 1063 
CYP102A3 O08336 534/1068(50%) 703/1068(65%) 19/1068(1%) 1055 
CYP102A2 O08394 530/1075(49%) 
  
705/1075(65%) 24/1075(2%) 1038 
CYP102A1 P14779 532/1070(50%) 720/1070(67%) 26/1070(2%) 1040 
CYP102A5 ADL27534 509/1047(49%) 
  
684/1047(65%) 21/1047(2%) 986 
CYP102D1 WP_010982013 456/1081(42%) 644/1081(59%) 27/1081(2%) 831 
















Protein; Krac9955 Accession number Identities Positives Gaps 
Score          
(out of  2254) 
      
Krac0936 EFH80345 550/1059(52%) 744/1059(70%) 24/1059(2%) 1118 
S. acidiphila WP_015249791 514/1076(48%) 697/1076(64%) 
  
21/1076(1%) 1037 
P. asaccharolytica WP_028931449 512/1072(48%) 690/1072(64%) 18/1072(1%) 1004 
S. niigatensis WP_026306974 489/1071(46%) 681/1071(63%) 26/1071(2%) 971 
N. multipartita WP_015747845 488/1074(45%) 673/1074(62%) 
  
21/1074(1%) 967 
A. broomeae WP_006019711 490/1089(45%) 
  
676/1089(62%) 24/1089(2%) 956 
V. paradoxus WP_019657533 489/1079(45%) 682/1079(63%) 
  
34/1079(3%) 955 
CYP102A13HaA2 ABD08340 484/1072(45%) 673/1072(62%) 22/1072(2%) 943 
CYP102A6 BAC48147 484/1090(44%) 
  
666/1090(61%) 31/1090(2%) 938 
CYP102A2 O08394 479/1076(45%) 665/1076(61%) 
  
38/1076(3%) 935 
CYP102A13BisB5 ABE39056 482/1086(44%) 669/1086(61%) 24/1086(2%) 934 
CYP102A7 WP_003183869 477/1074(44%) 655/1074(60%) 37/1074(3%) 904 
CYP102A3 O08336 460/1069(43%) 
  
652/1069(60%) 33/1069(3%) 891 
CYP102A5 ADL27534 463/1043(44%) 649/1043(62%) 
  
27/1043(2%) 884 
CYP102A1 P14779 444/1075(41%) 634/1075(58%) 41/1075(3%) 841 
CYP102D1 WP_010982013 388/1042(37%) 
  
583/1042(55%) 
   
 
31/1042(2%) 722 







Table 2 Comparative data and sequences for CYP102 family members. The sequences of conserved regions of the substrate entrance channel 
and the heme binding motif as well as the predicted pI and length of the amino acid chain are also provided. In the substrate entrance channel 
the Arg47 and Tyr51 residues of CYP102A1 have been highlighted in red. In the heme binding motif conserved residues are highlighted in 
bold. Sequences and nomenclature were obtained from the NCBI database or P450 homepage 
(http://drnelson.uthsc.edu/CytochromeP450.html).[32] 
Protein Accession number substrate entrance channel Heme binding motif pI AA 
Krac0936 EFH80345 AREL-GPIYQLEIPGRRT-VIVS YKPFGNGERACIG 5.2 1073 
Krac9955 EFH88481 AQRH-GPIFQLPLPDGTRRIVLS YKPFGTGQRSCIG 5.3 1079 
S. acidiphila AGA30711 AKEH-GPIYRLDLPGRKL-VILS YKPFGNGQRACIG 6.0 1080 
P. asaccharolytica WP_028931449 AQEY-GPLYKLTTPAGVR-LMVS YKPFGTGQRACIG 4.9 1076 
CYP102A1 P14779 ADEL-GEIFKFEAPGRVT-RYLS FKPFGNGQRACIG 5.0 1048 
CYP102A2 O08394 AKEQ-GPIFQLHTPAGTI-IVVS YKPFGNGQRACIG 5.4 1060 
CYP102A3 O08336 ADEL-GPIFRFDFPGVSS-VFVS YKPFGNGQRACIG 5.7 1053 
CYP102A5 ADL27534 AEEY-GPIFQIQTLSDTI-IVVS YKPFGNGQRACIG 5.7 1033 
CYP102A7 WP_003183869 ADEM-GPIFQFKFADAIG-VFVS YKPFGNGQRACIG 5.7 1073 
CYP102A13HaA2 ABD08340 AEEL-GPIFWLDMMGAPI-VIVS WKPFGNGQRACIG 6.2 1071 
CYP102D1 WP_010982013 SKQFPEGLYGMEIAGIEQ-VFVW YKPFGNGVRACIG 4.9 1072 
A. broomeae WP_006019711 TKEL-GPIFWLDMMGQPL-VIVS WKPFGNGQRACIG 6.4 1080 





Table 3 Potential active site residues of the Krac0936 and Krac9955 enzymes compared to those of other CYP102 family enzymes. The SRSs 
are based on those of CYP102A1 and those proposed for other CYP enzymes; SRS1 (69–92), SRS2 (181–188), SRS3 (200–208), SRS4 (I-helix, 
residues 253–271), SRS5 (325–335) and SRS6 (434–441). The amino acids in Krac0936 and Krac9955 which have been considered are given in 
brackets to the left and right of the SRS site, respectively. The equivalent residues of CYP102A1 are given at the bottom of each column. The 
residues of CYP102A1 that have previously been investigated are highlighted in red and underlined. Conserved residues (to CYP102A1) are 
highlighted in bold.  
 
 
CYP enzyme (72-101) SRS1 (64-93) (182-201) SRS2 (174-193) (202-217) SRS3 (194-209) 
Krac0936 FDKRVW-RPLQNVR-AFAGDGLFTAYTQEANW MGNALGESMARGRRLALQEK LMVNKHRQFQADVDFM 
S. acidiphila FDKLIS-TALGKVR-SFSGDGLFTAWTFEPNW MVRSLGESLLQANRLPLQEA LLFRTHRRHEQDIAYM 
A. broomeae FDKAVR-GALRRVR-AIGGDGLFTADTTEPNW LVRSL-ETIMMTRGLPLEGL FMRARRTDMAADVAFM 
CYP102A13HaA2 FDKAVR-GALRRVR-TVGGDGLFTADTSEPNW LVRSL-ETIMMTRGLPLENL WMKKRRDTLAEDVAFM 
V. paradoxus FDKSTR-GALRRLR-AAS-HGLFTSDTHEETW MVRTL-ETVQNRRGLPLEEL MLKKELAQQRKDIRYM 
Krac9955 FDKRVS-VNVRNLR-SAIGSGLFSADTSDPNW MVHILSTTAARATRPPIEEK LRFRQRRQLQADLDLL 
P. asaccharolytica FDKAVG-GGLSSLRGSVVSTGLFTAETDDPLW MVRSLLTAQARVRRLPIQNR LHIREQRQTEEDQIFM 
CYP102A2 FDKSIE-GALEKVR-AFSGDGLFTSWTHEPNW MVRALDEAMHQMQRLDVQDK LMIRTKRQFHHDIQAM 
CYP102A3 FDKNLG-KGLQKVR-EFGGDGLFTSWTHEPNW MLRALKEAMNQSKRLGLQDK MMVKTKLQFQKDIEVM 
CYP102A1 FDKNLS-QALKFVR-DFAGDGLFTSWTHEKNW MVRALDEAMNKLQRANPDDP AYDENKRQFQEDIKVM 
CYP102D1 FFKQIDKTPLAHVR-DYAGAGLFTAHQHEEEW LLQALVESLRRSQELPVMTK MRKADDKKYRENIRLM 
 (67-96) (177-196) (197-212) 
    
CYP enzyme (256-280) SRS4 (249-273) (331-352) SRS5 (323-345) (439-456) SRS6 (445-452) 
Krac0936 LNDVNIRYQIITFLIAGHETTSGLL ESLRLWPTAPLFSVYPYEETVV YELKIKQTLTLKPEGFTM 
S. acidiphila LDDVNIRYQILTFLIAGHETTSGLL ESLRLWPTAPAFALYPREETTL YRLRVKETLTLKPDGFTM 
A. broomeae LDDVNIRYQINTFLIAGHETTSGLL ESLRMWPPAPAYGVTPLKDETI YQMHLKETLTIKPDGFKI 
CYP102A13HaA2 LDDVNIRYQINTFLIAGHETTSGLL ETLRLWPPAPAYGVAPIQDETI YRMVLKETLTIKPEGFKI 
V. paradoxus LTDKMIRDECIEFLIAGHETTSGLL ESLRLYPTAPAISMRAKEETKI YKLKIKEALTIKPEGFRI 
Krac9955 LDDVNIRNQIITFLIAGHETTSGLL ETLRLCPTAPMFNRYPYEERPL YQLKIREALTIKPADFYM 
P. asaccharolytica LPDSNIQAQCITFLIAGHETTSGLL EALRLWPTAPAFTRAPFEDIVL YRLKTKTTLTIKPDDFRI 
CYP102A2 LDDENIRFQIITFLIAGHETTSGLL ESLRLWPTAPAFSLYAKEDTVI YELDIKQTLTLKPNDFHI 
CYP102A3 LDDENIRYQIITFLIAGHETTSGLL ETLRLYPTAPAFSLYAKEDTVL YELKIKEALTIKPDDFKI 
CYP102A1 LDDENIRYQIITFLIAGHETTSGLL EALRLWPTAPAFSLYAKEDTVL YELDIKETLTLKPEGFVV 
CYP102D1 LDDDNVRDQVVTFLIAGHETTSGLL ETLRLWAPIPMIGKSPLEDTVI YKMDVKEALTRKPGGFEL 
 (249-273) (321-342) (429-446) 
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Table 4 Product distribution data from the in vitro (in bold) and whole-cell turnover reactions 
(in italics) of Krac0936 and different fatty acids. The reported values for CYP102A1 are 
included (in brackets) for comparison.[8] The turnovers were analysed by GC-MS. The data 
are reported as the mean of at least three experiments. 








Krac0936- cis-9-hexadecanoic acid  
Krac0936- cis-9-octadecanoic acid 
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Table 5 Product distribution data from the in vitro and whole-cell turnover reactions (in italics) of Krac9955 with different fatty acids. The data 
are reported as the mean of at least three experiments. 
Substrate –  ω-1% ω-2% ω-3% ω-4% ω-5% ω-6% ω-7% ω-8% epox% 
decanoic 38 10 52 - - - - - - 
undecanoic 6 78 14 2 - - - - - 
dodecanoic 6  (7) 16 (18) 72 (69) 5 (4.5) 1 (0.5) - - - - 
tridecanoic 2 17 20 56 3 2 - - - 
tetradecanoic 1 7 14 34 41 2 2 - - 
pentadecanoic 1 2 10 26 20 37 2 2 - 
cis-9-tetradecanoic - - - - - 26 - - 74 
cis-9-hexadecanoic - - - - - - - 16 84 




Table 6 The relative NADPH oxidation activities and product formation rates for the 
Krac0936 turnovers of fatty acids. The coupling efficiency of the turnover of the fatty acids 
with Krac0936 and Krac9955 is also reported. The turnover activities were measured using a 
Krac0936 concentration of 0.2 μM in 50 mM Tris, pH 7.4. Coupling is the percentage 
efficiency of NADPH utilisation for the formation of products. The data are reported as a 
mean  S.D. (n  3) and the rates are given in nmol.nmol-CYP–1.min–1. 
 
 Krac0936a Krac9955a 
Substrate NADPH PFR Coupling Coupling 
decanoic - - - 7 ± 1 
undecanoic - - - 34 ± 1 
dodecanoic 15 ± 1 1 ± 0.2 8 ± 0.3 89 ± 6 
tridecanoic 246 ± 11 139 ± 7 57 ± 1 93 ± 4 
tetradecanoic 469 ± 7 392 ± 12 84 ± 2 69 ± 4 
pentadecanoic 951 ± 24 861 ± 13 91 ± 2 73 ± 4 
hexadecanoic 392 ± 5 236 ± 20 60 ± 4 - 
heptadecanoic 38 ± 0.6 13 ± 0.4 35 ± 1 - 
octadecanoic - - - - 
cis-9-tetradecanoic 15 ± 1 2.7 ± 0.1 19 ± 1 14 ± 1 
cis-9-hexadecanoic 210 ± 3 188 ± 9 89 ± 3 8 ± 1 
cis-9-octadecanoic 924 ± 11 296 ± 11 32 ± 1 - 
cis-9,12-octadecadienoic 1350 ± 19 880 ± 16 65 ± 1 - 
10-undecanoic - - - 12 ± 0.1 
 
a The alcohols dodecanol, tetradecanol, hexadecanol and the methyl esters methyl 
dodecanoate, methyl tetradecanoate were tested with Krac0936 and resulted in little or no 
NADPH oxidation above the leak rate. GC-MS analysis of the turnovers of these esters and 
alcohols with both Krac9955 and Krac0936 showed no detectable levels of product.  
No increase in the NAD(P)H oxidation activity was observed when replacing NADPH with 





Figures and Schemes 
 
Scheme 1 Product profiles of the Krac0936 catalysed turnovers of fatty acids. The same products are found in the turnovers of CYP102A1 with 












 (a)   (b)  
Figure 1 Phylogenetic tree of the (a) holoprotein and (b) heme domain only (residues 1-473) of selected CYP102 family enzymes including 
Krac9955 and Krac0936 (K. racemifer DSM44963 ) CYP102A1 (CYP102A1; B. megaterium), CYP102A2 (B. subtilis), CYP102A3 (B. subtilis), 
CYP102A5 (B. cereus), CYP102A6 (Bradyrhizobium diazoefficiens USDA 110), CYP102A7 (B. licheniformis), CYP102A11 (Erythrobacter sp. 
NAP1), CYP102A13HaA2 and CYP102A13BisB5 (the HaA2 and BisB5 strains of Rhodopseudomonas palustris), CYP102B2 and CYP102D1 
(both Streptomyces avermitilis), CYP101C2 (Rhodococcus erythropolis PR4), CYP102E1 (Ralstonia metallidurans), CYP102F1 (Actinosynnema 
pretiosum subsp. Auranticum) CYP102G1 (Streptomyces scabies) CYP102H1 (Nocardia farcinica), CYP102J1 (Burkholderia sp.) and the CYP102 
members from Singulisphaera acidiphila, Pseudonocardia asaccharolytica, Afipia broomeae and Variovorax paradoxus. Sequences and 
nomenclature were obtained from the NCBI database or P450 homepage (http://drnelson.uthsc.edu/CytochromeP450.html).[32] 
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Figure 2 GC-MS analyses of the BSTFA/TMSCl derivatised whole-cell oxidation turnovers 
of Krac0936 and Krac9955 (black) with dodecanoic acid. The substrate and products are 
labelled as are impurities (with an asterisk). The Krac0936 turnover has been offset slightly 








Figure 3 NADPH oxidation assays of (a) Krac0936 with dodecanoic (blue), tetradecanoic 
(red) and pentadecanoic (black) acids, and (b) pentadecanoic (black), cis-9-octadecenoic (red) 
and cis,cis-9,12-octadecadienoic (blue) acids. 
  (a) 
 





Figure 4 GC-MS analyses of the BSTFA/TMSCl derivatised in vitro turnovers of Krac0936 with (a) 
tridecanoic acid, (b) tetradecanoic acid, (c) pentadecanoic acid and (d) hexadecanoic acid. The substrate 
and products are labelled as are impurities (with an asterisk). 
 
(a)       (b) 
  






Figure 5 GC-MS analyses of the BSTFA/TMSCl derivatised in vitro turnovers of Krac9955 with (a) 
undecanoic acid, (b) tridecanoic acid, (c) tetradecanoic acid and (d) pentadecanoic acid. The substrate 
and products are labelled as are impurities (with an asterisk). 
 
a)       (b) 
  
 






Figure 6 GC-MS analyses of the BSTFA/TMSCl derivatised in vitro turnovers of Krac0936 with (a) 
cis-9-tetradecenoic acid, (b) cis-9-hexadecenoic acid, (c) cis-9-octadecenoic acid and (d) cis,cis-9,12-
octadecadienoic (linoleic) acid. The substrate and products are labelled as are impurities (with an 
asterisk). 
 
(a)       (b) 
  
 





Figure 7 GC-MS analyses of the BSTFA/TMSCl derivatised in vitro turnovers of Krac9955 with (a) 
cis-9-tetradecenoic acid and (b) 10-undecenoic acid. The substrate and products are labelled, as are 
impurities (with an asterisk). 
 
(a)       (b) 
  
 
 
 
 
